Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01690273
Other study ID # 8206212
Secondary ID
Status Completed
Phase N/A
First received September 18, 2012
Last updated February 12, 2014
Start date July 2012
Est. completion date June 2013

Study information

Verified date February 2014
Source University of Sao Paulo
Contact n/a
Is FDA regulated No
Health authority Brazil: Ethics Committee
Study type Interventional

Clinical Trial Summary

To evaluate the effects of stretching exercise in patients with ankylosing spondylitis at quality of life, functional capacity in patients with BASDAI lower than 4.Evaluate 40 patients with the diagnose of ankylosing spondylitis according to the criteria of the American College of rheumatology provenient from FMUSP at Clinical Hospital of São Paulo.


Description:

The evaluation complies BASFI, BASDAI, BASMI,BAS-G, ASQOL, SF 12,MASES, finger to floor distance, intermaleolar distance, lateral rotation of head, lateral flexion of the head, stiffness VAS, chest expasibility, Pavelka evaluation. All patients are allocatted randomly into 2 groups. One control with no exercise or group 1 with stretching exercise ( 30 minutes).


Recruitment information / eligibility

Status Completed
Enrollment 40
Est. completion date June 2013
Est. primary completion date June 2013
Accepts healthy volunteers No
Gender Both
Age group N/A and older
Eligibility Inclusion Criteria:

- Ankylosing spondylitis patient

- Basdai index lower than 4

- Physical inactive

- Functional class I to III

Exclusion Criteria:

- Fibromyalgia

- Cardiovascular disease

- Pain VAS over 8

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Supportive Care


Intervention

Other:
stretching exercise
30 minutes, twice a week

Locations

Country Name City State
Brazil University of Sao Paulo Sao Paulo

Sponsors (1)

Lead Sponsor Collaborator
University of Sao Paulo

Country where clinical trial is conducted

Brazil, 

References & Publications (1)

Yigit S, Sahin Z, Demir SE, Aytac DH. Home-based exercise therapy in ankylosing spondylitis: short-term prospective study in patients receiving tumor necrosis factor alpha inhibitors. Rheumatol Int. 2013 Jan;33(1):71-7. doi: 10.1007/s00296-011-2344-6. Epu — View Citation

Outcome

Type Measure Description Time frame Safety issue
Other patient evaluation quality of life BAS-G, ASQOL, SF 12 sixteen weeks Yes
Other flexibility FINGER TO FLOOR DISTANCE, intermaleolar distance,head lateral rotation , head lateral flexion, chest expansibility, Pavelka toracolumbar rotation. sixteen weeks Yes
Primary FUNCTIONAL INDEX BASFI - Bath ankylosyng spondylitis functional index sixteen weeks Yes
Secondary BASMI Bath ankylosing spondylitis motion index sixteen weeks Yes
See also
  Status Clinical Trial Phase
Terminated NCT02685904 - A Multicentre Study to Evaluate the Efficacy and Safety of ENIA11 in Patients With Ankylosing Spondylitis Phase 3
Completed NCT02186873 - A Study of Golimumab in Participants With Active Ankylosing Spondylitis Phase 3
Completed NCT01668004 - The Incidence of Extra-Articular Manifestations in Participants With Ankylosing Spondylitis Treated With Golimumab (MK-8259-012) Phase 4
Completed NCT05051943 - A Study of the Real-world Use of an Adalimumab Biosimilar and Evaluation of Nutritional Status on the Therapeutic Response
Completed NCT01934933 - Etanercept and Celecoxib Alone/Combined Treatment in Effectiveness and Safety of Active Ankylosing Spondylitis Phase 4
Not yet recruiting NCT04875299 - Optimal Adalimumab Plasma Concentrations in Ankylosing Spondylitis Patients
Completed NCT02758782 - NSAIDs Added to Anti-TNF Therapy Versus Anti-TNF Therapy Alone on Progression of Structural Damage in Ankylosing Spondylitis Phase 4
Completed NCT02763111 - Clinical Trial to Evaluate Efficacy and Safety of Multiple Subcutaneous Injections of Various Doses of BCD-085 in Patients With Active Ankylosing Spondylitis Phase 2
Active, not recruiting NCT02687620 - Does Immunogenicity Have an Influence on the Efficacy of Anti-TNF Therapy in Patients With AS: An Inception Cohort Study
Completed NCT02154425 - A Multicenter, Postmarketing Study Evaluating the Concentration of Cimzia® in Mature Breast Milk of Lactating Mothers Phase 1
Completed NCT01750528 - Prevalence and Progression of Periodontitis in Ankylosing Spondylitis N/A
Completed NCT01463189 - Web-based Support to Manage Arthritis Pain Phase 2
Completed NCT01091675 - Assessment of the Response to Etoricoxib in Patients With Ankylosing Spondylitis and Inadequate Response to ≥2 NSAIDs Phase 3
Completed NCT00844805 - Infliximab for Treatment of Axial Spondyloarthritis (P05336 AM1) Phase 3
Recruiting NCT00747578 - Health-Related Quality of Life and Disease-Related Costs: Comparison Between Ankylosing Spondylitis, Rheumatoid Arthritis and Systemic Lupus Erythematosus in Taiwan N/A
Completed NCT01083693 - Quality of Life Outcomes of HUMIRA in Rheumatoid Arthritis (RA), Psoriatic Arthritis (PsA), Ankylosing Spondylitis (AS) After Unsustainable Response to Biologicals and Disease Modifying Antirheumatic Drugs N/A
Completed NCT00715091 - Effects of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) on RAdiographic Damage in Ankylosing Spondylitis Phase 4
Not yet recruiting NCT00517101 - Presence of IBD Specific Antibodies (ASCA, ALCA, ACCA, AMCA) in the Sera of Patients With Spondyloarthropathy N/A
Completed NCT00367211 - Study to Evaluate the Incidence of Gastric Ulcers Following Administration of Either PN 200 or Naproxen in Subjects Who Are at Risk for Developing NSAID-Associated Ulcers. Phase 3
Completed NCT00133315 - TNFalfa Blocking Treatment of Spondylarthropathies Phase 4